Refine by
Blood Cell Products Articles & Analysis
31 news found
MedSource Labs Moves the Needle in the Peripheral Safety IV Market With the announcement of ClearSafe Comfort® and TrueSafe Comfort® Blood Control IV Catheters with groundbreaking active check valve ...
Peripheral blood mononuclear cells (PBMCs), derived from whole blood or leukapheresis, encompass several major immune cell populations including lymphocytes, monocytes, NK cells and dendritic cells. Apheresis material is a PBMC-enriched blood product widely used ...
For decades, medical professionals have used slow, cumbersome, imprecise water baths to thaw plasma. It’s time for a better way! Introducing ZipThaw: a dry, portable, rapid thawing device combined with our disposable ZipSleeve® anti-contamination barrier with heat sensors. As an alternative to water baths, dry plasma thawing is a groundbreaking innovation that unlocks numerous ...
ZipThaw is a blood product thawer that uses revolutionary dry technology to quickly thaw blood products for patients in need. ZipThaw is dry, so there’s no messes like with water baths, and fast, so you can increase your thawed plasma throughput — it’s also easy for staffers to use. With simple thawing, staffers can spend their time elsewhere on other critical tasks. Last ...
We’ve been on the road introducing ZipThaw, the revolutionary blood product thawing device, to military and civilian clinicians. This week we’re in Washington DC with Mark Rosenfeld of Genesis BPS. Here are some outtakes from the various shows and exhibitions. We’re grateful for the interest and flurry of new orders. ZipThaw is currently in use across the world! ...
“Pete is a great addition to our team and he is no stranger to our technology, as he conducted the feasibility study of automated production of ACP-01 in 2008. His knowledge and experience in developing highly engineered, commercially focused, automated production systems is a huge advantage as we move to scale production,” stated ...
About Hemostemix Hemostemix is a publicly traded autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company developed and has published seven peer reviewed articles about the safety and efficacy of its lead product ACP-01 as a treatment of CLI, PAD, Angina, Ischemic Cardiomyopathy, Dilated ...
CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announces its participation in two upcoming investor conferences. CytoSorbents will present at the Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 18, 2021. Dr. ...
About Hemostemix Hemostemix is a publicly traded autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company developed and has published seven peer reviewed articles about the safety and efficacy of its lead product ACP-01 as a treatment of CLI, PAD, Angina, Ischemic Cardiomyopathy, Dilated ...
About Hemostemix Hemostemix is a publicly traded autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company developed and has published seven peer reviewed articles about the safety and efficacy of its lead product ACP-01 as a treatment of CLI, PAD, Angina, Ischemic Cardiomyopathy, Dilated ...
“We are pleased to partner with Hemostemix and contribute our proprietary AI-based genomic and phenotypic tools, to enhance their ground-breaking personalized stem cell therapeutics. This collaboration exemplifies the power and precision of personalized autologous medicine,” stated Dr. ...
Kurin. Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture sets, announced the signing of a recent agreement with AllSpire Health GPO. The agreement is sole source and is for three years. “AllSpire Health GPO and Kurin are committed to patient safety by providing innovative solutions designed to address a common source of contaminated blood cultures and in doing ...
“I am particularly excited about the potential of ACP-01 to improve early engraftment, survival and function of transplanted human islets and stem cell products, and we are poised to explore this potential,” said Dr. ...
About Hemostemix Hemostemix is a publicly traded autologous stem cell therapy company, founded in 2003. A winner of the World Economic Forum Technology Pioneer Award, the Company developed and is commercializing its lead product ACP-01 for the treatment of CLI, PAD, Angina, Ischemic Cardiomyopathy, Dilated Cardiomyopathy and other conditions of ischemia. ...
The collaboration allows Focal Healthcare to develop a smart 3D ultrasound imaging platform for point of care use. TORONTO, CANADA – Focal Healthcare, known globally as a leading innovator of image-guided prostate cancer technology, is diversifying their product line by developing an AI-based 3D ultrasound imaging platform. Focal Healthcare has licensed patents from the Centre for Imaging ...
“For decades an autologous cell-based therapy for brain and spinal cord injuries has been the Holy Grail for neurological surgeons and their patients. ...
Kurin Inc., the inventor and manufacturer of 510(k)-cleared Kurin® blood culture collection sets, announced today a new clinical study supporting the efficacy of their blood culture collection product. Authors from Guy’s and St. Thomas’ NHS Foundation Trust, a prestigious London-based hospital, presented their data at the recent Infection Prevention Society conference in ...
With more than 300 patients treated compassionately with ACP-01 for ischemic cardiomyopathy, dilated cardiomyopathy, vascular dementia, COPD, and pulmonary hypertension, in this one-minute segment Peter recounts how his chest pain dissipated one week after his stem cell treatment, and he recounts how he felt like his life was back to normal after six weeks. ...
Instead, it targets and binds to the nucleolin protein and can enter cells that overexpress nucleolin. Viruses such as SARS-CoV-2 exploit nucleolin to gain access to a cell and manipulate it for its own viral replication purposes. ...
On May 31, 2021, Mr. Dominic Barton, Canadian Ambassador to China, accompanied by Consul General Jeff David and trade commissioners from the Canadian Consulate General in Chongqing, visited SWS ...